SFS
GSK icon

Stiles Financial Services’s GSK GSK Stock Holding History

Stiles Financial Services’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-5,308
Closed -$217K – 189
2024
Q3 		$217K Buy
5,308
+51
+1% +$2.09K 0.08% 173
2024
Q2 		$202K Buy
5,257
+52
+1% +$2.19K 0.08% 178
2024
Q1 		$223K Sell
5,205
-343
-6% -$14.1K 0.09% 166
2023
Q4 		$206K Sell
5,548
-460
-8% -$16.5K 0.09% 160
2023
Q3 		$218K Buy
6,008
+57
+1% +$2.02K 0.11% 161
2023
Q2 		$212K Sell
5,951
-42
-0.7% -$1.51K 0.11% 175
2023
Q1 		$213K Buy
5,993
+51
+0.9% +$1.78K 0.11% 168
2022
Q4 		$209K Buy
+5,942
New +$198K 0.12% 163

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Stiles Financial Services's GSK Position: Q4 2024 in Review

Stiles Financial Services sold out of GSK (GSK) in Q4 2024, closing a stake of 5,308 shares — an estimated $217K sold.

Stiles Financial Services first reported a position in GSK in Q4 2022 and held it in 8 quarters. The position peaked at $223K in Q1 2024. 848 funds tracked by Wall St. Rank hold GSK as of Q4 2024.

  • Stiles Financial Services reported no remaining GSK position as of Q4 2024 after selling out during the quarter.
  • Stiles Financial Services sold 5,308 GSK shares in Q4 2024, an estimated $217K.
  • Stiles Financial Services first reported a position in GSK in Q4 2022 and held it in 8 quarters.
  • Stiles Financial Services's GSK position peaked at $223K in Q1 2024.
  • 848 funds tracked by Wall St. Rank held GSK as of Q4 2024.

Based on Stiles Financial Services's 13F filing for Q4 2024, filed 28 Jan 2025.